Clinical Trial Update: Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, tolerability, and efficacy of donepezil in Parkinson's disease patients with dementia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Parkinson Disease

Drugs mentioned

• Donepezil (Aricept) (Donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Parkinson's Disease, Dementia | Phase 3 | Status: COMPLETED